Article Details

Concert Pharmaceuticals (NASDAQ:CNCE) Upgraded to Strong-Buy at BidaskClub

Retrieved on: 2019-03-23 16:48:45

Tags for this article:

Click the tags to see associated articles and topics

Concert Pharmaceuticals (NASDAQ:CNCE) Upgraded to Strong-Buy at BidaskClub. View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> LLC now owns 1,011,753 shares of the biotechnology company's stock valued at $12,698,000 after acquiring an additional ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up